Aetna, Cigna waive costs of coronavirus testing for members

Health insurers are jumping on board to provide free diagnostic and telemedicine services to members at high-risk of having the new coronavirus, COVID-19.

The costs associated with testing and care could prove to be barriers for those positive with the virus, which has claimed 10 lives in the U.S. and infected nearly 100 people as of March 5. Global cases of the disease, which includes symptoms such as cough, fever and trouble breathing, have topped 100,000.

Aetna, which is owned by CVS Health, will waive member fees for testing related to COVID-19, including copays. The health insurer will also provide telemedicine visits for any reason for free for the next 90 days. Telemedicine can lessen the risk of exposure to healthcare professionals and other patients at healthcare facilities. Aetna has decided to extend its Medicare Advantage virtual evaluation and monitoring visit benefit with full coverage to commercial members.

"Supporting the health and well-being of our members and removing barriers to care are among our key areas of focus as we navigate the spread of COVID-19," Karen S. Lynch, president of Aetna and executive vice president of CVS Health, said in a statement. "That's why we're providing COVID-19 diagnostic testing and telemedicine visits with no out-of-pocket costs or cost sharing for Aetna members, along with a number of other programs and offerings that reinforce our commitment to delivering timely and seamless access to care."

Both actions by Aetna have been recommended by several industry groups, including America’s Health Insurance Plans (AHIP), where Aetna is among its members.

Aetna also noted it is planning to send members who have tested positive for COVID-19 a care package with over-the-counter medications to relieve their symptoms as well as cleaning supplies to limit the risk to others in the household. Lastly, CVS Health noted it is opening crisis response lines for Aetna members who need help related to the new coronavirus; bringing its Aetna Nurse Medical Line, which is open 24/7, to all Aetna and Caremark members; and equipping plans sponsors to help treat with members with COVID-19-related anxiety though a Resources for Living toolkit with disease-specific materials.

Another major insurer, Cigna, similarly has opted to waive fees for its members who may need testing for coronavirus. This includes all copays or cost-shares, the company noted. Testing is currently available through the CDC at no cost and commercial testing is expected to “expand shortly,” according to Cigna’s announcement.

Cigna is waiving copays, coinsurance or deductibles for customers, including those enrolled in the company’s employer-sponsored plans in the U.S., Medicare Advantage, Medicaid and Affordable Care Act plans.

Cigna is also offering a 24/7 customer service resource center dedicated to those with coronavirus-related claims. The phone line aims to connect patients to qualified providers for support and guidance.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.